Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 63629-9689

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 63629-9689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636299689)

Label for oxybutynin chloride extended-release tablets USP 5 mg, showing the NDC 63629-9689-1. The label indicates the product is oral tablets, repackaged by Bryant Ranch Prepack and manufactured by Intas Pharmaceuticals Limited. The package contains 30 tablets and includes storage instructions and a barcode.*

FDA Label Image

Figure 1 (Oxybutynin Fig 1)

A line graph showing the mean plasma concentration of R-oxybutynin (ng/mL) over 24 hours for two dosing regimens: oxybutynin extended-release 10 mg once daily (QD) and oxybutynin 5 mg three times daily (TID). The y-axis represents mean plasma concentration, and the x-axis represents time in hours. Error bars indicate variability at each time point.*

FDA Label Image

Figure 2 (Oxybutynin Fig 2)

A line graph depicting mean R-oxybutynin plasma concentration (ng/mL) over time (hours). The graph shows plasma concentration measurements from 0 to 24 hours, with data points connected by a line and error bars indicating variability at each time point.*

FDA Label Image

Figure 4 (Oxybutynin Fig Study 1)

A horizontal bar chart comparing the effects of oxybutynin ER and placebo, with the x-axis spanning from -40 to 40 and the bars showing negative values for both treatments, the oxybutynin ER bar extending further left than the placebo bar.*

FDA Label Image

Figure 5 (Oxybutynin Fig Study 2)

A chart comparing oxybutynin ER and oxybutynin, showing mean values with error bars extending on both sides for each drug. The horizontal axis appears to represent a numerical scale ranging approximately from -40 to 40, with zero centered. No additional details or labels are clearly visible.*

FDA Label Image

Figure 6 (Oxybutynin Fig Study 3)

A horizontal bar chart comparing two entries labeled oxybutynin ER and oxybutynin. The chart has a scale ranging from -40 to 40, with the bars extending into the negative range.*

FDA Label Image

Chemical Structure (Oxybutynin Struc)

Chemical structure diagram of oxybutynin chloride showing its molecular composition with labeled chemical groups and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.